PRODUCT HIGHLIGHTS
- Oral Probiotic for Vaginal Health*
- Clinically-documented Benefits
- 20+ Years of Clinical Research
- Lactobacilli: GR-1® and RC-14®
- Prevention Mag: Top 10 Breakthroughs
What does Fem-Dophilus® do?
Fem-Dophilus® contains two clinically documented probiotic strains, Lactobacillus rhamnosus GR-1® and Lactobacillus reuteri RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1® and RC-14® to colonize and protect the vaginal tract.*
Clinical trials have shown that GR-1® and RC-14®:
- Help to restore & maintain vaginal health*
- Support health of the urinary tract*
Fem Dophilus® is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency.
The probiotic strains in Fem dophilus® are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.*
| Supplement Facts |
| Serving Size: 1 Capsule |
|
Amount Per Serving |
% DV |
| Total Probiotic Bacteria Lactobacillus rhamnosus GR-1 Lactobacillus reteri RC-14 |
5 Billion cfu |
* |
| *Daily Value not established. |
Other Ingredients
Dextrose anhydrate, potato starch, microcrystalline cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.
Contains: Dairy (casein, in trace amounts).
No wheat, no gluten, no soy, no egg, no fish/shellfish, no nuts/tree nuts.
Warnings
Keep out of the reach of children. Keep refrigerated.
